AFAR and TAME: A Brief History
The TAME trial is the brainchild of internationally renowned AFAR experts: Nir Barzilai, MD (Scientific Director), Steven Austad, PhD (Senior Scientific Director), James Kirkland, MD, PhD (President-Elect and grantee), David Sinclair, PhD (Board Member and grantee), S. Jay Olshansky, PhD (Board Member), and Stephanie Lederman (AFAR Executive Director).
At a 2014 scientific conference in Spain, members of this team, along with several other researchers, formed the idea for the TAME trial.
To date, AFAR has helped advance of the TAME Trial by convening major planning meetings, promoting the progress of the TAME Trial and its goals, and strategizing and securing funding partners. Once the TAME Trial is launched, AFAR will help share findings and insights through communications and conferences.